A preliminary research for the smart mobile system of monitoring adverse events in patients receiving lung cancer chemotherapy at outpatient setting (development number 02)
Phase 1
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000036002
- Lead Sponsor
- ational Center for Global Health and Medicine National College of Nursing, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
A person - who has no confirmed diagnosis - who cannot receive the standard treatment of cancer due to complications - who will receive less than 80% of prescribed dose with respect to all anti-cancer drugs in regimen - who receives chemoradiotherapy; radiation therapy and simultaneous chemotherapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method